US 8110354
Use of Shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo
granted A61KA61K2039/53A61K2039/543
Quick answer
US patent 8110354 (Use of Shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo) held by The United States of America as represented by the Secretary of the Army expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as represented by the Secretary of the Army
- Grant date
- Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/53, A61K2039/543, A61K2039/55516, A61K2039/55544